The Foundation is particularly interested in
specific research on:
the pharmacological control of plasma lipids, a recognised risk
factor in atherosclerosis;
prostaglandins, a family of short-life compounds whose extremely
differentiated activities affect the cells, organs, and systems
of the human body;
health and menopause.
many years, the Lorenzini Foundation has dedicated to the first two
subjects a series of Congresses of reconised value - "Drug Affecting
Lipid Metabolism" or DALM, and "Prostaglandins and Related
Compounds" - which are held in Italy or in the USA.
DALM and Prostaglandins Congresses now constitute a regular meeting
for the scientists of these two sectors of biomedical research.
Much of the research work presented for the first time at these congresses
subsequently received the Nobel Prize or other prestigious awards.
In recent years, the Foundation has been deeply committed to research
on the menopause and the many problems relating to this phase of a
the coming years, the Foundation will be heavily committed to expanding
and innovating its role in the diffusion of scientific culture not
only in Italy, but also throughout the rest of the world and, at the
same time, to consolidating its long-standing tradition of independence.
programs of the Foundation will focus on the scientific community,
both in Italy and abroad, as well as on the medical profession and
the wider community. In this context, the primary objective of the
Foundation is to seek consensus in the scientific world on health
themes of far-reaching importance for subsequent dissemination to
the community at large.
into atherosclerosis and its complications, one of the most widespread
diseases in Italy and in the world to-day will continue to play a
main role in the activities of the Lorenzini Foundation.
will the ongoing cooperation with the International Atherosclerosis
Society (IAS). These initiatives will continue to represent an arena
for the comparison and discussion of developing original theories
and for the most innovative experimental discoveries in the field
of physiopathology and treatment of the most widespread diseases in